ALPS Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,827
| Closed | -$889K | – | 1035 |
|
|
2022
Q1 | $889K | Sell |
3,827
-266
| -6% | -$61.8K | 0.01% | 322 |
|
|
2021
Q4 | $1.61M | Sell |
4,093
-62
| -1% | -$24.4K | 0.02% | 309 |
|
|
2021
Q3 | $1.86M | Sell |
4,155
-274
| -6% | -$123K | 0.02% | 327 |
|
|
2021
Q2 | $1.72M | Buy |
+4,429
| New | +$1.72M | 0.02% | 345 |
|
|
2019
Q2 | – | Sell |
-4,410
| Closed | -$4.38M | – | 881 |
|
|
2019
Q1 | $4.38M | Buy |
4,410
+190
| +5% | +$189K | 0.03% | 178 |
|
|
2018
Q4 | $3.67M | Buy |
4,220
+1,010
| +31% | +$877K | 0.03% | 179 |
|
|
2018
Q3 | $3.32M | Buy |
3,210
+677
| +27% | +$700K | 0.02% | 196 |
|
|
2018
Q2 | $2.33M | Buy |
2,533
+286
| +13% | +$263K | 0.02% | 217 |
|
|
2018
Q1 | $2.19M | Buy |
2,247
+891
| +66% | +$869K | 0.02% | 207 |
|
|
2017
Q4 | $614K | Buy |
1,356
+152
| +13% | +$68.8K | ﹤0.01% | 382 |
|
|
2017
Q3 | $498K | Buy |
1,204
+153
| +15% | +$63.3K | ﹤0.01% | 523 |
|
|
2017
Q2 | $368K | Buy |
1,051
+58
| +6% | +$20.3K | ﹤0.01% | 697 |
|
|
2017
Q1 | $510K | Sell |
993
-116
| -10% | -$59.6K | ﹤0.01% | 391 |
|
|
2016
Q4 | $394K | Sell |
1,109
-360
| -25% | -$128K | ﹤0.01% | 602 |
|
|
2016
Q3 | $786K | Buy |
+1,469
| New | +$786K | 0.01% | 233 |
|
|
2016
Q1 | – | Sell |
-1,509
| Closed | -$996K | – | 649 |
|
|
2015
Q4 | $996K | Sell |
1,509
-265
| -15% | -$175K | 0.01% | 218 |
|
|
2015
Q3 | $13.9K | Buy |
1,774
+808
| +84% | +$6.35K | 0.01% | 192 |
|
|
2015
Q2 | $1.27M | Buy |
+966
| New | +$1.27M | 0.01% | 196 |
|